• 1. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 2. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 3. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds C-nitro compounds
• Solvents and Organic Chemicals Organic Compounds Organic 1,3-dipolar compounds Allyl-type 1,3-dipolar organic compounds Organic nitro compounds C-nitro compounds

Research Brief on 6-Ethoxy-2-methyl-3-nitropyridine (CAS: 29546-49-4): Recent Advances and Applications

6-Ethoxy-2-methyl-3-nitropyridine (CAS: 29546-49-4) is a nitropyridine derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and organic synthesis. Recent studies have highlighted its potential as a key intermediate in the development of novel therapeutic agents, particularly in the areas of antimicrobial and anticancer research. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential industrial applications.

A 2023 study published in the Journal of Medicinal Chemistry explored the antimicrobial properties of 6-Ethoxy-2-methyl-3-nitropyridine derivatives. The research team synthesized a series of analogs and evaluated their efficacy against multidrug-resistant bacterial strains. The results indicated that certain derivatives exhibited potent inhibitory activity against Staphylococcus aureus and Escherichia coli, with minimum inhibitory concentrations (MICs) in the range of 2-8 μg/mL. These findings suggest that structural modifications of this compound could lead to the development of new antibiotics to address the growing issue of antimicrobial resistance.

In the realm of anticancer research, a recent Bioorganic & Medicinal Chemistry Letters publication (2024) investigated the compound's potential as a kinase inhibitor scaffold. Molecular docking studies revealed that 6-Ethoxy-2-methyl-3-nitropyridine derivatives could effectively bind to the ATP-binding site of several oncogenic kinases, particularly those involved in cell proliferation pathways. Subsequent in vitro assays demonstrated promising cytotoxic activity against various cancer cell lines, with IC50 values ranging from 5-20 μM. The study proposed that further optimization of the nitro and ethoxy substituents could enhance both potency and selectivity.

From a synthetic chemistry perspective, advancements have been made in the green synthesis of 6-Ethoxy-2-methyl-3-nitropyridine. A 2024 Green Chemistry article described a novel catalytic system using recyclable ionic liquids that achieved yields exceeding 85% while significantly reducing hazardous waste generation. This environmentally friendly approach addresses one of the key challenges in the industrial-scale production of nitropyridine derivatives, potentially lowering manufacturing costs and improving sustainability profiles.

The compound's physicochemical properties have also been the subject of recent computational studies. Density functional theory (DFT) calculations published in Computational and Theoretical Chemistry (2023) provided detailed insights into the electronic structure and reactivity of 6-Ethoxy-2-methyl-3-nitropyridine. These computational models help predict sites for electrophilic and nucleophilic attacks, facilitating the design of more efficient synthetic routes and novel derivatives with tailored biological activities.

In conclusion, 6-Ethoxy-2-methyl-3-nitropyridine (CAS: 29546-49-4) continues to be a valuable scaffold in pharmaceutical research, with recent studies expanding its potential applications in antimicrobial and anticancer drug development. The combination of synthetic chemistry advances, biological evaluations, and computational modeling approaches provides a comprehensive foundation for future research directions. Further investigation into structure-activity relationships and in vivo efficacy studies will be crucial for translating these findings into clinically relevant therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)